Company profile
AKL Research & Development Limited is a UK company with status active founded in 2013.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzODI3NTI3MmFkaXF6a2N4
Published 03 Oct 2024 09:20
Company registered at Companies House
1 Mar 2019 to 31 May 2019
"AKLRD, a UK SME, is seeking funding to take APPA, a new drug for treating Osteoarthritis (OA), through proof of concept clinical testing. OA, a degenerative joint disease, leads to increasing immobility, chronic pain and ultimately costly joint replacement. In the UK, 8.75 million people have sought treatment for OA and it is a growing problem linked to ...
1 Aug 2014 to 31 Jan 2015
AKL, a UK SME, has developed a novel therapeutic, APPA, for the treatment of osteoarthritis, a growing chronic disease affecting more than 8.5m people in the UK. It intends to use its innovation voucher to underpin the manufacture and production of APPA.
